Director, HCP Marketing & Omnichannel, IBRANCE & Next-Gen BC Brands

SUMMARY Pfizer Commercial Oncology is introducing the world to the next era of cancer care. With a growing portfolio of novel therapies, industry-leading R&D, and a goal of delivering eight breakthroughs by 2030 across major cancer types, we're translating cutting-edge science into market-shaping impact. Here, you'll partner with exceptional colleagues across scientific, medical, and manufacturing teams, backed by advanced digital and AI-enabled infrastructure and the authority to accelerate medicines from discovery to delivery. Guided by our values of courage, excellence, equity, and joy, you'll have the opportunity to stretch your skills and build a career that evolves with you—across teams, roles, and the Pfizer enterprise.  Join us to make history — for patients, for their families, for the future.  IBRANCE changed the treatment paradigm for metastatic breast cancer when it launched in 2015. As the brand approaches loss of exclusivity (LOE), this role owns its omnichannel and HCP marketing engine through the LOE timeframe and then carries that same omnichannel discipline forward to stand up NPP and digital execution for the Oncology Business Unit's next wave of breast cancer launches. This is a role for a marketing leader who thrives on solving complex problems in a competitive market and wants both halves of the brand lifecycle; defending an in-line asset through the tape, and building the omnichannel foundation a new set of launches will be built on. This individual must be able to excel in a fast-paced, matrixed environment, make immediate business impact, think outside the box, and actively contribute to a positive team culture. This role will focus on non-personal promotion (NPP), owning IBRANCE's nonpromotional strategy and digital/omnichannel execution (paid search, organic search, paid social, web analytics, search AI, media strategy, programmatic planning, etc.). As IBRANCE approaches LOE, the role will transition into a forward-looking role supporting NPP launch activities for Prifetrastat, a new asset entering the Oncology Business Unit's portfolio. The role requires strong strategic and analytical thinking, clear communication, lateral leadership, sharp project management, and a track record of delivering on a large matrix team while operating in ambiguity. Expect significant collaboration with US Commercial, Legal, Medical, Regulatory, Sales, Global, Operations, and Market Access. Reports to the US IBRANCE / BC Pipeline Brand Lead. The BC team is a large, dynamic team with significant opportunity, so responsibilities may shift over time based on business needs and individual interest.

RESPONSIBILITIES Omnichannel & HCP Marketing Leadership (IBRANCE) Media & Agency Operations: direct ownership of the specialized workstreams now in-housed by CMO (paid search, organic, paid social, web analytics, search AI, programmatic). Work closely with data science to monitor KPIs and overall brand performance, redefining media measurement approaches as needed Expanded Media & Digital Strategy: end-to-end annual media planning and quarterly performance read-outs Platform & Channel Troubleshooting: platform-level shifts (e.g., Meta format/compliance changes) and new channel launches Creative Asset Development: directing agency (CoLab) creative work across social, banner, video, and web HCP Accelerator Change Champion: Lead transformation in audience targeting and engagement across omnichannel platforms, including retargeting capabilities Influencer Ad Board Contributor: Provide strategic input on influencer standardization and champion HCP influencer integration across therapeutic areas Lead LOE DAW Execution Support: Partner with brand and cross-functional leadership to drive planning and execution of IBRANCE's Dispense as written strategy as it approaches Next-Gen Launch Omnichannel Foundation (Beginning ahead of IBRANCE LOE) As IBRANCE nears LOE, this role increasingly turns its omnichannel expertise toward